Advertisement

Community Health Workers: a Resource to Support Antipsychotic Medication Adherence

  • Caitlin G. Allen
  • Michael A. Sugarman
  • Ashley Wennerstrom
Article
  • 490 Downloads

Abstract

Community health workers (CHWs) are frontline public health workers who are becoming increasingly integrated into medical settings for the prevention, treatment, and control of chronic disease. In particular, they have demonstrated the ability to improve medication adherence in underserved populations. One overlooked population that could benefit from CHW intervention is individuals with severe mental illnesses such as schizophrenia and bipolar disorder. These conditions are disproportionally weighted to economically disadvantaged communities and people of color, and are typically treated using antipsychotic medications. A number of factors, including social disadvantage, contribute to antipsychotic non-adherence, which is highly prevalent and drastically increases the burden of illness and economic impact of these conditions. This commentary examines the ways in which CHWs may be able to best serve individuals with severe mental illness, and proposes methods for facilitating this expanded scope of work.

Keywords

Schizophrenia Bipolar Disorder Antipsychotic Medication Severe Mental Illness Community Health Worker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    IMS Health. Top Theraputic Classes by U.S. Spending. IMS. Available online at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/Press Room/Top_line_data/Top_Therapy_Classes_by_Sales.pdf. Accessed September 22, 2015.
  2. 2.
    Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Mededicine 2005;353(12):1209–1223.CrossRefGoogle Scholar
  3. 3.
    Lage MJ, Hassan MK. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Annals of General Psychiatry 2009;8:7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Subotnik KL, Nuechterlein KH, Ventura J, et al. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. American Journal of Psychiatry 2011;168(3):286–292.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 2001;52(6):805–811.CrossRefPubMedGoogle Scholar
  6. 6.
    Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry 2005;66(9):1122–1129.CrossRefPubMedGoogle Scholar
  7. 7.
    Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin 1995;21(3):419–429.CrossRefPubMedGoogle Scholar
  8. 8.
    Mitchell AJ, Selmes T. Why don’t patients take their medicine? Reasons and solutions in psychiatry. Advances in Psychiatric Treatment 2007;13:336–346.CrossRefGoogle Scholar
  9. 9.
    Robinson DG, Woerner MG, Alvir J, et al. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 2002;57(2–3):209–19.CrossRefPubMedGoogle Scholar
  10. 10.
    Alegria M, Canino G, Rios R, et al. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatric Services 2002;53(12):1547–1555.CrossRefPubMedGoogle Scholar
  11. 11.
    Alegria M, Chatterji P, Wells K, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatric Services 2008;59(11):1264–1272.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sajatovic M, Valenstein M, Blow FC, et al. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders 2006;8(3):232–241.CrossRefPubMedGoogle Scholar
  13. 13.
    Schwartz RC, Blankenship DM. Racial disparities in psychotic disorder diagnosis: A review of empirical literature. World Journal of Psychiatry 2014;4(4):133–140.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Muntaner C, Eaton WW, Miech R, et al. Socioeconomic position and major mental disorders. Epidemiogy Review 2004;26:53–62.CrossRefGoogle Scholar
  15. 15.
    Casagrande SS, Gary TL, LaVeist TA, et al. Perceived discrimination and adherence to medical care in a racially integrated community. Journal of General Internal Medicine 2007;22:389–395.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Gilkey M, Garcia CC, Rush C. Professionalization and the experience-based expert: strengthening partnerships between health educators and community health workers. Health Promotion Practice 2011;12(2):178–182.CrossRefPubMedGoogle Scholar
  17. 17.
    Brownstein JN, Allen CG. Addressing chronic disease through community health workers: a policy and systems-level approach; Centers for Diseaes Control and Prevention, 2015. Available online at: http://www.cdc.gov/dhdsp/docs/chw_brief.pdf. Accessed May 11, 2016.
  18. 18.
    American Public Health Association. Policy Number 20091: Support for community health workers to increase health access and to reduce health inequities [online]. Available online at: http://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/09/14/19/support-for-community-health-workers-to-increase-health-access-and-to-reduce-health-inequities. Accessed January 6, 2013.
  19. 19.
    Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of Community Health Workers in the care of people with hypertension. American Journal of Preventive Medicine 2007;32(5):435–447.CrossRefPubMedGoogle Scholar
  20. 20.
    Findley SE, Matos S, Hicks AL, et al.. Community health worker integration into the health care team accomplishes the triple aim in a patient-centered medical home: a Bronx tale. Journal of Advanced Nursing 2014;37(1):82–91.Google Scholar
  21. 21.
    Norris SL, Chowdhury FM, Van Le K, et al. Effectiveness of Community Health Workers in the care of persons with diabetes. Diabetic Medicine 2006;23(5):544–556.CrossRefPubMedGoogle Scholar
  22. 22.
    Thompson J, Horton C, Flores C. Advancing diabetes self-management in the Mexican American population: a community health worker model in a primary care setting. Diabetes Education 2007;33(Supplement 6):159S-165SCrossRefGoogle Scholar
  23. 23.
    Allen CG, Brownstein JN, Jayapaul-Philip B, et al. Strengthening the Effectiveness of State Level Community Health Worker Initiatives through Ambulatory Care Partnerships. The Journal of Ambulatory Care Management 2015;38(3):254–262.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Wennerstrom A, Hargrove L, Minor S, et al. Integrating Community Health Workers Into Primary Care to Support Behavioral Health Service Delivery: A Pilot Study. Journal of Ambulatory Care Management 2015;38(3):263–272.CrossRefPubMedGoogle Scholar
  25. 25.
    Wennerstrom A, Vannoy S, Allen CE, et al. Community-based participatory development of community health worker mental health outreach role to extend collaborative care in post-Katrina New Orleans. Ethnicity and Disease 2011;21(3 Suppl 1):45–51.Google Scholar
  26. 26.
    O’Riordan M. Use of Community Health Workers Improved Adherence following ACS. Paper presented at: World Congress of Cardiology Scientific Session, Melbourne, Austraila, 2014.Google Scholar
  27. 27.
    The Community Guide. Cardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers. Available online at: http://www.thecommunityguide.org/cvd/CHW.html. Accessed September 2, 2015.
  28. 28.
    Sabaté, E. Adherence to long-term therapies: evidence for action. World Health Organization. Geneva, Switzerland, 2003.Google Scholar
  29. 29.
    Rosenthal EL, Wiggins N, Brownstein JN, et al. The Final Report of the National Community Health Advisor Study: Weaving the Future. University of Arizona. Available online at http://www.chw-nec.org/pdf/CAHsummaryALL.pdf. Accessed September 22, 2015.
  30. 30.
    Katon W, Robinson P, VonKorff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Archive of General Psychiatry 1996;53(10):924–932.CrossRefGoogle Scholar
  31. 31.
    Lin EH, VonKorff M, Katon W, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Medical Care 1995;33(1):67–74.CrossRefPubMedGoogle Scholar
  32. 32.
    Katon W, Lundman RC, VonKorff M, et al. A randomized trial of relapse prevention of depression in primary care. Archive of General Psychiatry 2001;2001(58):3.Google Scholar
  33. 33.
    Becker D, Yanek L, Johnson W. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation 2005;15(111):1298–1304.CrossRefGoogle Scholar
  34. 34.
    Ho PM, Bryson CL, Rumsfield JS. Medication Adherence: Its Importance in Cardiovascular Outcomes. Circulation 2009;119(3028–3035).CrossRefPubMedGoogle Scholar
  35. 35.
    Peweler R, George C, Kinmonth A,, et al.. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. British Medical Journal 1999;319:612–615.CrossRefGoogle Scholar
  36. 36.
    Morrison AP, Hutton P, Shiers D,, et al.. Antipsychotics: is it time to introduce patient choice? The British Journal of Psychiatry 2012;201:83–84.CrossRefPubMedGoogle Scholar
  37. 37.
    Harrow M, Jobe TH, Faull RN. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychology Medicine 2012;42(10):2145–2155.CrossRefGoogle Scholar
  38. 38.
    Wunderink L, Nieboer RM, Wiersma D, et al. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry 2013;70(9):913–920.CrossRefPubMedGoogle Scholar
  39. 39.
    Jonsdottir H, Opjordsmoen S, Birkenaes AB, et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatria Scandinavica 2013;127(1):23–33.CrossRefGoogle Scholar
  40. 40.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archchives of Internal Medicine 2000;160(14):2101–2107.CrossRefGoogle Scholar
  41. 41.
    DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology 2004;23(2):207–218.CrossRefPubMedGoogle Scholar
  42. 42.
    Buchanan J. Social support and schizophrenia: a review of the literature. Archives of Psychiatric Nursing 1995;9(2):68–76.CrossRefPubMedGoogle Scholar
  43. 43.
    Whaley AL. Cultural mistrust of white mental health clinicians among African Americans with severe mental illness. American Journal of Orthopsychiatry 2001;71(2):252–256.CrossRefPubMedGoogle Scholar
  44. 44.
    Kreyenbuhl J, Buchanan RW, Dickerson FB, et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations. Schizophrenia Bulletin 2010;26:94–103.CrossRefGoogle Scholar
  45. 45.
    Burns AM, Erickson DH, Brenner CA. Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review. Psychiatric Services 2014;65(7):874–80.CrossRefPubMedGoogle Scholar
  46. 46.
    Davidson L, O’Connell M, Tondora J, et al. The top ten concerns about recovery encountered in mental health system transformation. Psychiatric Services 2006;57(5):640–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Owen PR. Portrayals of schizophrenia by entertainment media: a content analysis of contemporary movies. Psychiatry Services 2012;63(7):655–659.CrossRefGoogle Scholar
  48. 48.
    Swartz MS, Swanson JW, Hiday VA, et al. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. American Journal of Psychiatry 1998;155(2):226–231.PubMedGoogle Scholar

Copyright information

© National Council for Behavioral Health 2016

Authors and Affiliations

  • Caitlin G. Allen
    • 1
  • Michael A. Sugarman
    • 2
  • Ashley Wennerstrom
    • 3
  1. 1.Department of MedicineBoston UniversityBostonUSA
  2. 2.Department of PsychologyWayne State UniversityDetroitUSA
  3. 3.Department of MedicineTulane University School of MedicineNew OrleansUSA

Personalised recommendations